Terilogy Holdings Corporation
Financial Summary for the Six Months Ended March 2027 (Q2 Interim)
Net sales were 4,897 million yen, up 6.6% year-over-year. Operating loss was 265 million yen, ordinary loss was 198 million yen, and net loss attributable to owners of parent for the interim period was 185 million yen. No revision to full-year earnings guidance. Share buyback activity executed. Orders received were 5,928 million yen and order backlog was 5,565 million yen.
Key Figures
- Net Sales: 4,897 million yen (Up 6.6% YoY)
- Orders Received: 5,928 million yen (Up 8.4% YoY)
- Order Backlog: 5,565 million yen (Up 18.8% YoY)
AI要約
Overview of Performance
In the six months ended March 2027 (Q2 interim), Terilogy Holdings Corporation reported net sales of 4,897 million yen, an increase of 6.6% year-on-year. However, the company recorded an operating loss of 265 million yen, an ordinary loss of 198 million yen, and a net loss attributable to owners of parent of 185 million yen for the interim period. Orders received totaled 5,928 million yen and order backlog was 5,565 million yen, both showing solid trends. Rising material costs, foreign exchange fluctuations, and increased man-hours for introducing new products exerted temporary pressure on gross margin and profits. Financial position shows net assets of 2,943 million yen, an equity ratio of 26.4%, and cash and deposits of 3,461 million yen.
Outlook and Impact for Investors
While performance during the period showed signs of recovery, the company has not revised its full-year earnings guidance in this financial summary. Terilogy Holdings Corporation will continue capital and human-resource investments while focusing on expanding orders and promoting its own products and services. In the short term, investors should monitor raw material prices and currency risks; for sustainable improvement in results, cost management and the market impact of new product launches will be key.
Terilogy Holdings Corporation
Company overview · Stock price · Financial data · All IR